Moderna (MRNA) moved up to the #415 position in S&P 500 market-cap rankings, overtaking Generac Holdings (GNRC). The article is a ranking update based on market capitalization rather than an operating or earnings development. It is largely informational and unlikely to have a meaningful near-term price impact.
Moderna (MRNA) moved up to the #415 position in S&P 500 market-cap rankings, overtaking Generac Holdings (GNRC). The article is a ranking update based on market capitalization rather than an operating or earnings development. It is largely informational and unlikely to have a meaningful near-term price impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
